|
|
Article: Immune Response Cuts Staff To Focus On Remune; CEO Resigns.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
The Immune Response Corp. said Monday it is reducing its staff in an effort to cut costs by $1.8 million per quarter while narrowing its focus to its most advanced product, the HIV therapeutic vaccine, Remune.
The Carlsbad, Calif.-based company also said that following a meeting Friday of its board, CEO and President Dennis Carlo resigned and the company appointed Ronald Moss as president. Carlo had been CEO since 1994, while Moss, who joined the company as medical director in 1994, had served in other positions before being named vice president, medical and scientific affairs in January 2000.
The company had $1.1 million in cash as ...
Related newspaper, magazine, and journal articles:
|
|
Article: COMPANY FORGING AHEAD WITH DIABETES DRUG AMYLIN STOCK DROPS 77 ...
BIOWORLD Today;
October 22, 1998 ;
700+ words
... ... price dropped below $8.50. (See BioWorld Today, Aug. 19, 1997, p. 1.) Along ... U.S. and Europe," Krawiec told BioWorld Today. Tanner said Amylin's move to continue ... J $36 million from a loan. (See BioWorld Today, March 3, 1998, p. 1.) Terms ...
|
|